KENDRA STARK: Open Payments
NPI 1376325126 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 28 payments from 12 companies in 2025. Trend: 2023 $16 · 2024 $920 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $82 |
| Actelion Pharmaceuticals US, Inc. | 4 | $75 |
| Alnylam Pharmaceuticals Inc. | 2 | $66 |
| HEARTFLOW, INC. | 1 | $45 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $30 |
| Boston Scientific Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: VYNDAQEL, LEQVIO, AMVUTTRA, FFRct, VERQUVO, UPTRAVI, JARDIANCE, OPSUMIT.
Industry payments across IN — which companies pay providers there.
